FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (ScieGen Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for hydrochlorothiazide from ScieGen Pharmaceuticals, Inc., under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Edema
• Hypertension

Drugs mentioned

• HYDROCHLOROTHIAZIDE (hydrochlorothiazide)

Snippet

SUPPL AP for HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE)